Bibliography

Filters: First Letter Of Keyword is U  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T [U] V W X Y Z   [Show ALL]
E
Eriksen MB, Frandsen TF. The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review. J Med Libr Assoc. 2018;106(4):420-31. Abstract
Eisenberg JM, Zarin D. Health technology assessment in the United States. Past, present, and future. Int J Technol Assess Health Care. 2002;18(2):192-8.
Eisenberg JM, Zarin D. Health technology assessment in the United States. Past, present, and future. Int J Technol Assess Health Care. 2002;18(2):192-8.
Eisenberg JM, Zarin D. Health technology assessment in the United States. Past, present, and future. Int J Technol Assess Health Care. 2002;18(2):192-8.
D
Duthie K, Bond K. Improving ethics analysis in health technology assessment. Int J Technol Assess Health Care. 2011;27(1):64-70. Abstract
Dracos A. [SIBIL: an information tool for the information retrieval on bioethics]. Ann Ist Super Sanita. 2004;40(3):283-6. Abstract
Dracos A. [SIBIL: an information tool for the information retrieval on bioethics]. Ann Ist Super Sanita. 2004;40(3):283-6. Abstract
Dracos A. [SIBIL: an information tool for the information retrieval on bioethics]. Ann Ist Super Sanita. 2004;40(3):283-6. Abstract
Dracos A. [SIBIL: an information tool for the information retrieval on bioethics]. Ann Ist Super Sanita. 2004;40(3):283-6. Abstract
C
Cranovsky R, Schilling J, Faisst K, Koch P, Gutzwiller F, Brunner HH. Health technology assessment in Switzerland. Int J Technol Assess Health Care. 2000;16(2):576-90. Abstract
Cooper C, Booth A, Britten N, Garside R. A comparison of results of empirical studies of supplementary search techniques and recommendations in review methodology handbooks: a methodological review. Syst Rev. 2017;6(1):234. Abstract
Cooper C, Booth A, Britten N, Garside R. A comparison of results of empirical studies of supplementary search techniques and recommendations in review methodology handbooks: a methodological review. Syst Rev. 2017;6(1):234. Abstract
Carroll C. Qualitative evidence synthesis to improve implementation of clinical guidelines. BMJ. 2017;356:j80.
Callahan D. Health technology assessment implementation: the politics of ethics. Med Decis Making. 2012;32(1):E13-9. Abstract
B
Bridges JF, Jones C. Patient-based health technology assessment: a vision of the future. Int J Technol Assess Health Care. 2007;23(1):30-5. Abstract
Brett Hauber A, Fairchild AO, Reed Johnson F. Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature. Appl Health Econ Health Policy. 2013;11(4):319-29. Abstract
Bramer WM, Rethlefsen ML, Mast F, Kleijnen J. Evaluation of a new method for librarian-mediated literature searches for systematic reviews. Res Synth Methods. 2018;9(4):510-20. Abstract
Boyle S. United Kingdom (England): Health system review. Vol 13 (1). Mossialos E, Busse R, Figueras J, McKee M, Saltman R, editors. Copenhagen: WHO Regional Office for Europe; 2011. Abstract
Berndt K, Hinzpeter B, Kurscheid T, Lauterbach KW. [Conception and conversion of medical technology assessment--an international comparison]. Z Arztl Fortbild Qualitatssich. 1998;92(4):255-62. Abstract
Beckles Z, Glover S, Ashe J, Stockton S, Boynton J, Lai R, et al. Searching CINAHL did not add value to clinical questions posed in NICE guidelines. J Clin Epidemiol. 2013;66(9):1051-7. Abstract
Battista RN, Hodge MJ. The development of health care technology assessment. An international perspective. Int J Technol Assess Health Care. 1995;11(2):287-300. Abstract
Basch E. Toward patient-centered drug development in oncology. N Engl J Med. 2013;369(5):397-400.
Basch E. Beyond the FDA PRO guidance: steps toward integrating meaningful patient-reported outcomes into regulatory trials and US drug labels. Value Health. 2012;15(3):401-3.
Basch E, Torda P, Adams K. Standards for patient-reported outcome-based performance measures. JAMA. 2013;310(2):139-40.
Basch E. Beyond the FDA PRO guidance: steps toward integrating meaningful patient-reported outcomes into regulatory trials and US drug labels. Value Health. 2012;15(3):401-3.